sponsored byAAAS Golden Fund

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 1-25 out of 1343.

1 | 2 | 3 | 4 | 5 > >>

Public Release: 26-Apr-2017
Building Research & Information
Study finds major health benefits linked to indoor temperature variation
Exposure to environments outside a comfortable temperature could help tackle major metabolic diseases, such as diabetes and obesity.

Contact: Krystina Sihdu
newsroom@taylorandfrancis.com
020-701-76928
Taylor & Francis Group

Public Release: 25-Apr-2017
Scientific Reports
Managing disease spread through accessible modeling
A new computer modeling study from Los Alamos National Laboratory is aimed at making epidemiological models more accessible and useful for public-health collaborators and improving disease-related decision making.
Defense Threat Reduction Agency

Contact: Nancy Ambrosiano
nwa@lanl.gov
505-667-0471
DOE/Los Alamos National Laboratory

Public Release: 25-Apr-2017
Centennial Celebration of Bacteriophage Research
Novel phage therapy saves patient with multidrug-resistant bacterial infection
Scientists and physicians at University of California San Diego School of Medicine, working with colleagues at the US Navy Medical Research Center -- Biological Defense Research Directorate (NMRC-BDRD), Texas A&M University, a San Diego-based biotech and elsewhere, have successfully used an experimental therapy involving bacteriophages -- viruses that target and consume specific strains of bacteria -- to treat a patient near death from a multidrug-resistant bacterium.

Contact: Scott LaFee
slafee@ucsd.edu
858-249-0456
University of California - San Diego

Public Release: 25-Apr-2017
Radiology
Artificial intelligence may help diagnose tuberculosis in remote areas
Researchers are training artificial intelligence models to identify tuberculosis (TB) on chest X-rays, which may help screening and evaluation efforts in TB-prevalent areas with limited access to radiologists, according to a new study.

Contact: Linda Brooks
lbrooks@rsna.org
630-590-7762
Radiological Society of North America

Public Release: 24-Apr-2017
Phytomedicine
Patients with drug-resistant malaria cured by plant therapy developed at WPI
When the standard malaria medications failed to help 18 critically ill patients, the attending physician in a Congo clinic acted under the 'compassionate use' doctrine and prescribed a not-yet-approved malaria therapy made only from the dried leaves of the Artemisia annua plant. In just five days, all 18 people fully recovered. This small but stunningly successful trial is detailed in a new paper in Phytomedicine by lead author Pamela Weathers at Worcester Polytechnic Institute (WPI).

Contact: Michael Dorsey
mwdorsey@wpi.edu
508-831-5609
Worcester Polytechnic Institute

Public Release: 24-Apr-2017
European Congress of Clinical Microbiology and Infectious Diseases
Measuring immune response could be key to differentiating malaria from other infections
Analyzing a patient's immune response could be key to quickly and accurately diagnosing malaria, according to research presented on World Malaria Day at the 27th European Congress of Clinical Microbiology and Infectious Diseases.
Bill and Melinda Gates Foundation, NIH/National Institute of Allergy and Infectious Diseases

Contact: Kerry Noble
kerry_noble@hotmail.com
44-744-686-9433
European Society of Clinical Microbiology and Infectious Diseases

Public Release: 24-Apr-2017
Scientific Reports
Tiny 'cages' could keep vaccines safe at high temperatures
Vaccines and antibodies could be transported and stored without refrigeration by capturing them in tiny silica 'cages', a discovery which could make getting vital medicines to patients much easier, cheaper and safer.
Royal Society, The Annett Trust

Contact: Chris Melvin
c.m.melvin@bath.ac.uk
44-012-253-83941
University of Bath

Public Release: 24-Apr-2017
American Journal of Tropical Medicine and Hygiene
Malaria sickening thousands in US and racking up millions in healthcare costs, new study finds
A new study published today in the American Journal of Tropical Medicine and Hygiene shows that malaria led to a count of hospitalized patients and deaths that easily eclipsed other travel-related illness and generated about half a billion dollars in healthcare costs in the US over a 15-year period.

Contact: Carol Schadelbauer
carol@burness.com
301-280-5725
Burness

Public Release: 23-Apr-2017
Philosophical Transactions of the Royal Society B
Conservation not an effective tool for reducing infectious disease in people, study finds
A new study finds that improved human health is not a benefit of conservation -- at least when health is measured through the lens of infectious disease. The paper analyzed the relationship between infectious diseases and their environmental, demographic and economic drivers in dozens of countries over 20 years.

Contact: Michelle Ma
mcma@uw.edu
206-543-2580
University of Washington

Public Release: 22-Apr-2017
Experimental Biology 2017
4 exciting advances in food and nutrition research
New discoveries tied to how food affects our body and why we make certain food choices could help inform nutrition plans and policies that encourage healthy food choices. The Experimental Biology 2017 meeting (EB 2017) will showcase groundbreaking research in food policy, nutrition and the biochemistry of food.

Contact: Anne Frances Johnson
media@experimentalbiology.org
571-271-1986
Experimental Biology 2017

Public Release: 21-Apr-2017
Researchers receive $9 million grant for research on drug-resistant malaria
The University of Maryland School of Medicine has been awarded a $9 million seven-year grant to develop new tools against drug-resistant malaria in Southeast Asia.
NIH/National Institute of Allergy and Infectious Diseases

Contact: David Kohn
dkohn@som.umaryland.edu
410-706-7590
University of Maryland School of Medicine

Public Release: 21-Apr-2017
NIH funds UC San Diego Amazonian Center of Excellence in Malaria Research
The Amazonian Center of Excellence for Malaria Research, headed by Joseph Vinetz, M.D., professor of medicine and tropical disease specialist at University of California San Diego School of Medicine, will receive up to approximately $8.3 million over seven years from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
National Institutes of Health

Contact: Scott LaFee
slafee@ucsd.edu
858-249-0456
University of California - San Diego

Public Release: 21-Apr-2017
PLOS ONE
Sunflower seeds traced as source of toxic mold, potent liver carcinogen
Michigan State University researchers have shown that sunflower seeds are frequently contaminated with a toxin produced by molds and pose an increased health risk in many low-income countries worldwide.

Contact: Layne Cameron
layne.cameron@cabs.msu.edu
517-353-8819
Michigan State University

Public Release: 21-Apr-2017
The International Liver CongressTM 2017
WHO's Global Hepatitis Report sets baseline to eliminate viral hepatitis by 2030
The World Hepatitis Alliance today welcomes the publication of the first-ever Global Hepatitis Report by the World Health Organization (WHO), which includes new data on the prevalence and global burden of viral hepatitis.

Contact: Tara Farrell
Tara.farrell@worldhepatitisalliance.org
44-776-162-5256
World Hepatitis Alliance

Public Release: 21-Apr-2017
The International Liver CongressTM 2017
Journal of Hepatology
Blood donor screening for hepatitis E reveals incidence is higher than previously reported
Results from a study presented today found that the incidence of HEV RNA in asymptomatic blood donors from Germany is higher than previously reported. The study, presented at The International Liver Congress™ 2017 in Amsterdam, The Netherlands, showed that 0.11 percent of donations tested were HEV RNA positive and that one of the asymptomatic HEV RNA positive donors had previously donated HEV RNA positive blood products, which were then transfused into nine immunocompromised patients.

Contact: ILC press office
ilcpressoffice@ruderfinn.co.uk
44-078-410-09252
European Association for the Study of the Liver

Public Release: 21-Apr-2017
The International Liver CongressTM 2017
Journal of Hepatology
Investigational dose of oral interferon-free treatment can cure hepatitis C in children
A study presented today that evaluated an investigational dosage of once-daily ledipasvir 45 mg/sofosbuvir 200 mg (LDV/SOF) in children aged six to 11 years infected with HCV, found that 99 percent of children had undetectable levels of HCV-RNA 12 weeks after treatment. The study, presented at The International Liver Congress™ 2017 in Amsterdam, The Netherlands, showed that the fixed-dose combination of LDV/SOF was well-tolerated, and no patients experienced serious adverse events related to the study drug.

Contact: ILC press office
ilcpressoffice@ruderfinn.co.uk
44-078-410-09252
European Association for the Study of the Liver

Public Release: 20-Apr-2017
PLoS ONE
Bringing the 'magic' of ultrasound to rural Uganda to reduce pregnancy complications
In a collaborative study, a team of researchers found that radio advertising for free ultrasounds in rural Uganda increased the number of pregnant women who attended modern medical care by 490 per cent.
Bridge to Health Medical and Dental

Contact: Robert DeLaet
robert.delaet@lawsonresearch.com
519-685-8500 x75664
Lawson Health Research Institute

Public Release: 20-Apr-2017
PLOS Neglected Tropical Diseases
PLOS Neglected Tropical Diseases celebrates 10th anniversary
The recently published 10th Anniversary Collection in PLOS NTDs marks the journal's important milestone with retrospective pieces featuring over 20 NTDs. The articles in the collection reflect on significant lessons and successes in the field over the past decade as well as identify some of the remaining challenges. Together, they lay out a road map for future research priorities, identifying key opportunities for further progress in disease elimination.

Contact: PLOS Neglected Tropical Diseases
plosntds@plos.org
PLOS

Public Release: 20-Apr-2017
SIAM Journal on Applied Dynamical Systems
Periodic model predicts the spread of Lyme disease
Lyme disease is among the most common vector-borne illnesses in North America, Europe, and some parts of Asia. A spirochete bacterium called Borrelia burgdorferi causes the disease, and blacklegged ticks are responsible for the majority of North American transmissions. In a paper publishing next week in the SIAM Journal on Applied Dynamical Systems, Xiunan Wang and Xiao-Qiang Zhao present a mathematical model of Lyme disease that incorporates seasonality and climate factors.

Contact: Lina Sorg
sorg@siam.org
267-350-6371
Society for Industrial and Applied Mathematics

Public Release: 20-Apr-2017
PLOS Pathogens
On the brink of eradication: Why polio research matters
In the decades since Dr. Jonas Salk developed the first polio vaccine, cases of polio have exponentially declined. Though once widespread epidemic, the highly infectious childhood disease is now close to global eradication. The question remains: why would researchers spend time and resources studying a virus already on the brink of total eradication?

Contact: PLOS Pathogens
plospathogens@plos.org
PLOS

Public Release: 19-Apr-2017
Cell Host & Microbe
Defective HIV proviruses reduce effective immune system response, interfere with HIV cure
A new study finds defective HIV proviruses, long thought to be harmless, produce viral proteins and distract the immune system from killing intact proviruses needed to reduce the HIV reservoir and cure HIV. The study was published by researchers at the George Washington University and Johns Hopkins University in Cell Host & Microbe.
National Institutes for Health, amfAR generationCURE

Contact: Lisa Anderson
lisama2@gwu.edu
202-994-3121
George Washington University

Public Release: 19-Apr-2017
European Journal of Preventive Cardiology
Personalized workouts to prevent heart disease designed by new digital instrument
Personalized workouts to prevent heart disease can be designed by a new digital instrument, according to research published today in the European Journal of Preventive Cardiology. The EXPERT tool specifies the ideal exercise type, intensity, frequency, and duration needed to prevent a first or repeat cardiovascular event.
UHasselt IOF PoC project

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 19-Apr-2017
The Lancet
Widely disparate spending on health forecast through 2040
Spending on health care by nations is expected to increase significantly over the next two decades, but the rates of increase and sources of spending will differ widely, according to a new analysis.
Bill & Melinda Gates Foundation

Contact: Dean Owen
dean1227@uw.edu
206-434-5630
Institute for Health Metrics and Evaluation

Public Release: 19-Apr-2017
The International Liver CongressTM 2017
Journal of Hepatology
ILC 2017: Four new EASL clinical practice guidelines on the management of liver diseases
The European Association for the Study of the Liver (EASL) today announced that four new Clinical Practice Guidelines (CPGs) will be presented at The International Liver Congress™ 2017 in Amsterdam, The Netherlands, and published in the Journal of Hepatology, EASL's official journal. CPGs define the use of diagnostic, therapeutic and preventive modalities, including non-invasive and invasive procedures, in the management of patients with various liver diseases.

Contact: ILC press office
ilcpressoffice@ruderfinn.co.uk
44-078-410-09252
European Association for the Study of the Liver

Public Release: 18-Apr-2017
Nature Microbiology
Researchers identify tactic Dengue virus uses to delay triggering immune response
Mount Sinai researchers describe novel mechanism cells use to recognize earliest stages of infection and how virus evades triggering an immune response.

Contact: Lucia Lee
newsmedia@mssm.edu
212-241-9200
The Mount Sinai Hospital / Mount Sinai School of Medicine

Showing releases 1-25 out of 1343.

1 | 2 | 3 | 4 | 5 > >>